Generic placeholder image

CNS & Neurological Disorders - Drug Targets


ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries

Author(s): Emanuela Esposito and Salvatore Cuzzocrea

Volume 12, Issue 1, 2013

Page: [55 - 61] Pages: 7

DOI: 10.2174/1871527311312010010

Price: $65


The role of palmitoylethanolamide (PEA) in the regulation of complex systems involved in the inflammatory response, pruritus, neurogenic and neuropathic pain is well understood. Growing evidence indicates that this Nacylethanolamine also exerts neuroprotective effects within the central nervous system (CNS), i.e. in spinal cord and traumatic brain injuries and in age-related pathological processes. PEA is abundant in the CNS, and is produced by glial cells. Several studies show that administering PEA during the first few hours after injury significantly limits CNS damage, reduces loss of neuronal tissue and improves functional recovery. PEA appears to exert its protective effect by decreasing the development of cerebral edema, down-regulating the inflammatory cascade, and limiting cellular necrosis and apoptosis. All these are plausible mechanisms of neuroprotection. This review provides an overview of current knowledge of PEA effect on glial functions in the brain and how targeting glial-specific pathways might ultimately impact the development of therapies for clinical management of neurodegenerative disorders. The diverse signaling mechanisms are also summarized.

Keywords: Glial cells, N-acylethanolamine, neuroprotection, spinal cord

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy